Difficulty: Medium
Average Score: 86%
Practice
The present status of oral hypoglycaemics in diabetes mellitus is
Correct answer
D
Rationale
The correct answer is D) They are used first in most uncomplicated mild to moderate type II diabetics.
Explanation:
Oral hypoglycemic agents are commonly used as the first-line treatment in individuals with type 2 diabetes mellitus. This is because type 2 diabetes is characterized by insulin resistance and relative insulin deficiency, making oral medications more suitable for managing blood glucose levels initially.
Option A) They are the first choice drugs in all cases: This is incorrect because while oral hypoglycemic agents are commonly used, they may not be the first choice in all cases, especially in severe or advanced stages of diabetes where insulin therapy may be necessary.
Option B) They should be prescribed only if the patient refuses insulin injections: This is incorrect as oral hypoglycemic agents are not limited to cases where patients refuse insulin injections. They are often used as a primary treatment option based on the individual's condition and needs.
Option C) They are used only in type I diabetes mellitus: This is incorrect as oral hypoglycemic agents are primarily indicated for type 2 diabetes mellitus due to the underlying insulin resistance seen in this condition. Type 1 diabetes typically requires insulin therapy.
Educational Context:
Understanding the appropriate use of oral hypoglycemic agents in diabetes management is crucial for healthcare professionals involved in the care of diabetic patients. By recognizing the role of these medications as first-line therapy in mild to moderate type 2 diabetes, healthcare providers can make informed decisions to optimize patient outcomes and prevent complications associated with uncontrolled blood sugar levels. It is essential to tailor treatment plans to individual patient needs, considering factors such as disease severity, comorbidities, and patient preferences.
Explanation:
Oral hypoglycemic agents are commonly used as the first-line treatment in individuals with type 2 diabetes mellitus. This is because type 2 diabetes is characterized by insulin resistance and relative insulin deficiency, making oral medications more suitable for managing blood glucose levels initially.
Option A) They are the first choice drugs in all cases: This is incorrect because while oral hypoglycemic agents are commonly used, they may not be the first choice in all cases, especially in severe or advanced stages of diabetes where insulin therapy may be necessary.
Option B) They should be prescribed only if the patient refuses insulin injections: This is incorrect as oral hypoglycemic agents are not limited to cases where patients refuse insulin injections. They are often used as a primary treatment option based on the individual's condition and needs.
Option C) They are used only in type I diabetes mellitus: This is incorrect as oral hypoglycemic agents are primarily indicated for type 2 diabetes mellitus due to the underlying insulin resistance seen in this condition. Type 1 diabetes typically requires insulin therapy.
Educational Context:
Understanding the appropriate use of oral hypoglycemic agents in diabetes management is crucial for healthcare professionals involved in the care of diabetic patients. By recognizing the role of these medications as first-line therapy in mild to moderate type 2 diabetes, healthcare providers can make informed decisions to optimize patient outcomes and prevent complications associated with uncontrolled blood sugar levels. It is essential to tailor treatment plans to individual patient needs, considering factors such as disease severity, comorbidities, and patient preferences.